Company Filing History:
Years Active: 2006
Title: Amy L Helgerson: Innovator in Viral Purification Technologies
Introduction
Amy L Helgerson is a notable inventor based in Charlton, MA (US). She has made significant contributions to the field of viral purification, particularly in therapeutic applications. Her work focuses on improving methods for purifying adenovirus and adeno-associated virus (AAV), which are crucial for gene therapy procedures.
Latest Patents
Amy L Helgerson holds a patent for the "Purification of adenovirus and AAV." This invention relates to the purification of large-scale quantities of active (infectious) adenovirus and AAV. The improved methods she developed minimize or eliminate damage to the virus during contact with chromatographic materials. This advancement allows for the rapid and efficient purification of commercial-level quantities of active virus suitable for therapeutic applications.
Career Highlights
Amy is associated with Genzyme Corporation, where she applies her expertise in viral purification technologies. Her innovative approaches have the potential to enhance the effectiveness of gene transfer and therapy procedures.
Collaborations
Some of her notable coworkers include Catherine E O'Riordan and Alan E Smith. Their collaborative efforts contribute to the advancement of research in the field of viral purification.
Conclusion
Amy L Helgerson's work in the purification of adenovirus and AAV represents a significant advancement in therapeutic applications. Her contributions are vital for the future of gene therapy and related fields.